methylphenidate has been researched along with Recrudescence in 24 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although neuroleptics are the major treatment for schizophrenia, there are no effective measures to determine the appropriate or necessary length of neuroleptic maintenance." | 5.27 | Methylphenidate challenge as a predictor of relapse in schizophrenia. ( Brenner, R; Gadaleta, D; Kane, JM; Kinon, B; Lesser, MS; Lieberman, JA, 1984) |
| "Methylphenidate has been shown to be an effective therapy in patients with refractory neurocardiogenic syncope." | 3.78 | Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome. ( Grubb, BP; Kanjwal, K; Kanjwal, Y; Karabin, B; Saeed, B, 2012) |
| "Hospital charts were reviewed for 66 medical and surgical patients who received dextroamphetamine or methylphenidate to treat a depressive disorder." | 3.67 | Psychostimulant treatment of depressive disorders secondary to medical illness. ( Cassem, NH; Murray, GB; Tesar, GE; Woods, SW, 1986) |
| "Methylphenidate was tapered and discontinued during weeks 9 and 10." | 2.71 | Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. ( Kim, MD; Kumar, A; Lavretsky, H; Reynolds, CF, 2003) |
| "Psychotherapy is still the mainstay of treatment; however, relapse rates are high." | 2.44 | Pharmacotherapy of methamphetamine addiction: an update. ( Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W, 2008) |
| "We consider drug-induced cerebral vasculitis as the most likely cause of recurrent ischaemic strokes in the absence of any pathological findings during the diagnostic work-up." | 1.33 | Cerebral vasculitis following oral methylphenidate intake in an adult: a case report. ( Kucinski, T; Röther, J; Thomalla, G; Weiller, C, 2006) |
| "Although neuroleptics are the major treatment for schizophrenia, there are no effective measures to determine the appropriate or necessary length of neuroleptic maintenance." | 1.27 | Methylphenidate challenge as a predictor of relapse in schizophrenia. ( Brenner, R; Gadaleta, D; Kane, JM; Kinon, B; Lesser, MS; Lieberman, JA, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Aryan, N | 1 |
| Banafshe, HR | 1 |
| Farnia, V | 1 |
| Shakeri, J | 1 |
| Alikhani, M | 1 |
| Rahimi, H | 1 |
| Sehat, M | 1 |
| Mamsharifi, P | 1 |
| Ghaderi, A | 1 |
| Omidi, A | 1 |
| Benard, V | 1 |
| Cottencin, O | 1 |
| Guardia, D | 1 |
| Vaiva, G | 1 |
| Rolland, B | 1 |
| Luo, YX | 1 |
| Xue, YX | 1 |
| Liu, JF | 1 |
| Shi, HS | 1 |
| Jian, M | 1 |
| Han, Y | 1 |
| Zhu, WL | 1 |
| Bao, YP | 1 |
| Wu, P | 1 |
| Ding, ZB | 1 |
| Shen, HW | 1 |
| Shi, J | 1 |
| Shaham, Y | 1 |
| Lu, L | 1 |
| Elkashef, A | 1 |
| Vocci, F | 1 |
| Hanson, G | 1 |
| White, J | 1 |
| Wickes, W | 1 |
| Tiihonen, J | 1 |
| Manor, I | 1 |
| Gutnik, I | 1 |
| Ben-Dor, DH | 1 |
| Apter, A | 1 |
| Sever, J | 1 |
| Tyano, S | 1 |
| Weizman, A | 1 |
| Zalsman, G | 1 |
| Kanjwal, K | 1 |
| Saeed, B | 1 |
| Karabin, B | 1 |
| Kanjwal, Y | 1 |
| Grubb, BP | 2 |
| Wang, GJ | 1 |
| Smith, L | 1 |
| Volkow, ND | 1 |
| Telang, F | 1 |
| Logan, J | 1 |
| Tomasi, D | 1 |
| Wong, CT | 1 |
| Hoffman, W | 1 |
| Jayne, M | 1 |
| Alia-Klein, N | 1 |
| Thanos, P | 1 |
| Fowler, JS | 1 |
| Brouns, SH | 1 |
| Schieveld, J | 1 |
| Leue, C | 1 |
| Woolley, JB | 1 |
| Heyman, I | 1 |
| Lavretsky, H | 1 |
| Kim, MD | 1 |
| Kumar, A | 1 |
| Reynolds, CF | 1 |
| Thomalla, G | 1 |
| Kucinski, T | 1 |
| Weiller, C | 1 |
| Röther, J | 1 |
| Kratochvil, CJ | 1 |
| Varley, C | 1 |
| Cummins, TK | 1 |
| Martin, A | 1 |
| Wolf, U | 1 |
| Golombek, U | 1 |
| Diefenbacher, A | 1 |
| Lieberman, JA | 5 |
| Kane, JM | 4 |
| Gadaleta, D | 2 |
| Brenner, R | 1 |
| Lesser, MS | 1 |
| Kinon, B | 1 |
| Alvir, J | 2 |
| Geisler, S | 1 |
| Ramos-Lorenzi, J | 3 |
| Woerner, M | 2 |
| Novacenko, H | 2 |
| Cooper, T | 1 |
| Arcand, M | 1 |
| Hottin, P | 1 |
| Huessy, HR | 2 |
| Kosinski, D | 1 |
| Mouhaffel, A | 1 |
| Pothoulakis, A | 1 |
| Phillips, KA | 1 |
| Albertini, RS | 1 |
| Siniscalchi, JM | 1 |
| Khan, A | 1 |
| Robinson, M | 1 |
| Sarantakos, S | 1 |
| Woods, SW | 1 |
| Tesar, GE | 1 |
| Murray, GB | 1 |
| Cassem, NH | 1 |
| Gadaletta, D | 1 |
| Bergmann, K | 1 |
| Wegner, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment Study for Frontotemporal Dementia[NCT00088751] | 20 participants | Observational | 2004-07-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for methylphenidate and Recrudescence
| Article | Year |
|---|---|
Pharmacotherapy of methamphetamine addiction: an update.
Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; | 2008 |
Prediction of outcome in first-episode schizophrenia.
Topics: Antipsychotic Agents; Dopamine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Growth Hormo | 1993 |
[Treatment of depression in the elderly. The use of psychostimulants].
Topics: Age Factors; Aged; Amphetamines; Comorbidity; Contraindications; Dementia; Depressive Disorder; Huma | 1993 |
3 trials available for methylphenidate and Recrudescence
| Article | Year |
|---|---|
Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants | 2003 |
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.
Topics: Adolescent; Adult; Blinking; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Follow-Up Studie | 1994 |
Prediction of relapse in schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Blinking; Dopamine Antagonists; Dyskinesia | 1987 |
18 other studies available for methylphenidate and Recrudescence
| Article | Year |
|---|---|
The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder.
Topics: Adult; Amphetamine-Related Disorders; Behavior Therapy; Central Nervous System Stimulants; Combined | 2020 |
The impact of discontinuing methylphenidate on weight and eating behavior.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Body Mass Index; Central Nervous System S | 2015 |
A novel UCS memory retrieval-extinction procedure to inhibit relapse to drug seeking.
Topics: Animals; Basolateral Nuclear Complex; Behavior, Animal; Central Nervous System Stimulants; Cocaine; | 2015 |
Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents - a pilot study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorb | 2010 |
Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Fatigue; Female; Follow-Up Studies; Humans; Ma | 2012 |
Decreased dopamine activity predicts relapse in methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; D | 2012 |
[The Kleine-Levin syndrome and the treatment with methylphenidate].
Topics: Adolescent; Central Nervous System Stimulants; Humans; Kleine-Levin Syndrome; Male; Methylphenidate; | 2012 |
Dexamphetamine for obsessive-compulsive disorder.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; | 2003 |
Cerebral vasculitis following oral methylphenidate intake in an adult: a case report.
Topics: Acute Disease; Adult; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System S | 2006 |
Less is more: inpatient management of a child with complex pharmacotherapy.
Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depressio | 2006 |
[Diagnosis and treatment of the attention-deficit/hyperactivity syndrome (ADHS) in adults with drug addiction in in-patient and out-patient setting].
Topics: Adult; Alcoholism; Ambulatory Care; Attention Deficit Disorder with Hyperactivity; Borderline Person | 2006 |
Methylphenidate challenge as a predictor of relapse in schizophrenia.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Infusions, Parenteral; Male; Methy | 1984 |
The use of antidepressants in the treatment of children with behaviour disorders.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorder | 1993 |
The use of methylphenidate in the treatment of refractory neurocardiogenic syncope.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Bradycardia; Central Nervous S | 1996 |
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Buspirone; Child; Drug Administ | 2001 |
Psychostimulant treatment of depressive disorders secondary to medical illness.
Topics: Adjustment Disorders; Adult; Aged; Dementia; Depression; Depressive Disorder; Dextroamphetamine; Fem | 1986 |
Adolescents and ritalin.
Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Humans; Methylphenida | 1985 |
Methylphenidate challenge tests and course of schizophrenia.
Topics: Adolescent; Adult; Female; Growth Hormone; Humans; Male; Methylphenidate; Middle Aged; Prognosis; Pr | 1985 |